Please check your internet connection and try again.
# Lorazepam
## Overview
Lorazepam is a benzodiazepine medication with anxiolytic, sedative, hypnotic, amnestic, anticonvulsant, and muscle relaxant properties. It acts by enhancing the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABAA receptor, resulting in a decrease in neuronal excitability.
## Primary Indications
* Anxiety disorders
* Insomnia due to anxiety or transient situational stress
* Status epilepticus
* Preanesthetic medication to induce sedation and reduce anxiety
## Adult Dosing
* **Anxiety:** 0.5 mg to 2 mg orally 2 to 3 times daily. Maximum daily dose: 10 mg.
* **Insomnia:** 1 mg to 2 mg orally at bedtime.
* **Status Epilepticus:** 4 mg slow IV injection or IM injection. Repeat in 5 to 10 minutes if seizure persists. Maximum dose: 8 mg.
* **Preanesthetic Medication:** 2 mg to 4 mg IM 2 hours before surgery.
*Dosing for specific indications may vary based on local protocols and individual patient factors.*
## Pediatric Dosing
Dosing in pediatric patients is less well-established and requires careful consideration of age, weight, and clinical condition.
* **Status Epilepticus:** 0.05 mg/kg to 0.1 mg/kg IV, maximum 4 mg per dose. May repeat once after 5 to 10 minutes.
* **Sedation:** Dosing is highly variable and should be determined by the treating physician, often ranging from 0.02 mg/kg to 0.1 mg/kg IM or IV.
*Parenteral dosing in pediatric patients should be administered by trained personnel with appropriate monitoring capabilities.*
## Dose Adjustments
* **Hepatic Impairment:** Use with caution; dosage reduction may be necessary.
* **Renal Impairment:** No specific dosage adjustment is typically recommended for mild to moderate renal impairment, but caution is advised.
* **Elderly:** Start with lower doses (e.g., 0.5 mg orally twice daily) and titrate cautiously due to increased sensitivity and risk of sedation, falls, and cognitive impairment.
## Contraindications
* Known hypersensitivity to benzodiazepines or any component of the formulation.
* Acute narrow-angle glaucoma.
* Severe respiratory insufficiency.
* Severe hepatic insufficiency.
* Sleep apnea syndrome.
## Adverse Effects
Common: Drowsiness, dizziness, weakness, unsteadiness, fatigue.
Less Common: Confusion, depression, amnesia, blurred vision, hypotension, paradoxical excitation.
## Key Drug Interactions
* **CNS Depressants (e.g., alcohol, opioids, other sedatives):** Additive CNS depression, potentially leading to profound sedation, respiratory depression, coma, and death. Use together with extreme caution or avoid.
* **Theophylline, Aminophylline:** May decrease the sedative effects of lorazepam.
* **Valproic Acid:** May increase lorazepam plasma concentrations.
## Monitoring
* Monitor for signs of sedation, respiratory depression, dizziness, and falls, especially in elderly patients or those receiving other CNS depressants.
* Assess for paradoxical reactions (e.g., excitement, aggression).
* For status epilepticus, monitor seizure activity, vital signs, and respiratory status.
* Observe for signs of dependence and withdrawal symptoms with prolonged use.
## Clinical Pearls
* Lorazepam has a relatively short half-life compared to some other benzodiazepines, which may be advantageous in certain situations but can also lead to more frequent dosing or withdrawal symptoms upon abrupt cessation.
* Intramuscular (IM) absorption can be less predictable than intravenous (IV) or oral administration.
* Avoid abrupt discontinuation; taper gradually to minimize withdrawal symptoms.
* When used for status epilepticus, lorazepam is often a first-line agent, but other agents may be used depending on local protocols and patient response.
---
**Disclaimer:** This information is intended for clinical professionals. Always consult the most current prescribing information and relevant guidelines for complete details, indications, contraindications, warnings, precautions, and adverse reactions before making any treatment decisions.
